From the moment you discover you’re pregnant, you know you have a lot to prepare for. Even if it’s not your first rodeo, there’s always something new to learn, especially when it comes to your baby’s health. Educating yourself on how to protect your baby’s future health is just another part of the process, and there’s one valuable resource that lives right inside of your baby’s umbilical cord that can help.
A resource for their future health
Cord blood, which is the blood inside your baby’s umbilical cord has powerful stem cells that help your baby develop organs, blood, tissue, and an immune system during pregnancy. After your baby is born, the blood and stem cells can be collected and saved for potential use in future treatments.
Having this valuable resource at your fingertips is something that a lot of parents-to-be might not know about until now. That’s why November 15th is World Cord Blood Day. It aims to bring awareness to how important storing your baby’s cord blood can be if you ever need it. In celebration of World Cord Blood Day, we’re offering $175 off Cord Blood and Cord Tissue banking. Use Code: WEBNOV175 to enroll online or call 866-668-4895.
What can cord blood stem cells do?
Cord blood stem cells have the unique ability to help rebuild a healthy immune system damaged by disease. Cord blood has been used in transplant medicine for over 30 years and can be used in the treatment of nearly 80 different diseases today.* Over the last few years, cord blood use has expanded beyond transplant medicine into clinical research trials for conditions like autism and brain injuries making this an exciting and perfect time to bank your baby’s cord blood for your family’s potential future use.
Celebrating Cord Blood
In celebration of World Cord Blood Day, let’s take a look back at some important milestones*:
Families Using Cord Blood
Over 450 ViaCord families have used their banked cord blood in transplant medicine or clinical research. As research around this fascinating science continues to grow, more and more families are choosing to bank their baby’s stem cells.
Waller-Wise, R. (2011). Umbilical cord blood: information for childbirth educators. Retrieved from https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3209739/
About Us. (n.d.). Retrieved from https://nybloodcenter.org/about-us/nybc-overview/pablo-rubinstein-md/
Kurtzberg, Joanne. “A History of Cord Blood Banking and Transplantation.” Stem Cells Translational Medicine, John Wiley and Sons Inc., May 2017, https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5442723/.
Laughlin, Mary J., et al. “Hematopoietic Engraftment and Survival in Adult Recipients of Umbilical-Cord Blood from Unrelated Donors: NEJM.” New England Journal of Medicine, 14 June 2001, https://www.nejm.org/doi/full/10.1056/NEJM200106143442402
Cairo, M S, and J E Wagner. “Placental and/or Umbilical Cord Blood: an Alternative Source of Hematopoietic Stem Cells for Transplantation.” Blood, U.S. National Library of Medicine, 15 Dec. 1997, https://www.ncbi.nlm.nih.gov/pubmed/9389681?dopt=Abstract
Hughes. “Cord Blood Transplantation: Hallmarks of the 20th Century.” OUP Academic, Oxford University Press, 1 Dec. 2000, https://academic.oup.com/labmed/article/31/12/672/2504179
“Meet Jesse.” Insception Lifebank, https://www.insception.com/family-stories/meet-jesse/
Couto, Pedro S, et al. “The First Decade of Advanced Cell Therapy Clinical Trials Using Perinatal Cells (2005–2015).” The First Decade of Advanced Cell Therapy Clinical Trials Using Perinatal Cells (2005–2015) | Regenerative Medicine, 15 Nov. 2017, https://www.futuremedicine.com/doi/full/10.2217/rme-2017-0066
Harris, David T. “Cord Blood Stem Cells: a Review of Potential Neurological Applications.” Stem Cell Reviews, U.S. National Library of Medicine, Dec. 2008, https://www.ncbi.nlm.nih.gov/pubmed/18679834
Rocha, Vanderson, and Eliane Gluckman. “Improving Outcomes of Cord Blood Transplantation: HLA Matching, Cell Dose and Other Graft‐ and Transplantation‐Related Factors.” Wiley Online Library, John Wiley & Sons, Ltd (10.1111), 1 Oct. 2009, https://onlinelibrary.wiley.com/doi/full/10.1111/j.1365-2141.2009.07883.x?_sm_au_=iVVFDW7bMLjwk60FN4s4kKHFLKVG2
“Autologous Cord Blood Stem Cells for Autism – Full Text View.” Full Text View – ClinicalTrials.gov, https://clinicaltrials.gov/ct2/show/NCT01638819
Ballen, Karen K, et al. “Umbilical Cord Blood Transplantation: the First 25 Years and Beyond.” Blood, American Society of Hematology, 25 July 2013, https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3952633/
Dawson, Geraldine, et al. “Autologous Cord Blood Infusions Are Safe and Feasible in Young Children with Autism Spectrum Disorder: Results of a Single‐Center Phase I Open‐Label Trial.” Stem Cells Journals (AlphaMed Press), John Wiley & Sons, Ltd, 5 Apr. 2017, https://stemcellsjournals.onlinelibrary.wiley.com/doi/full/10.1002/sctm.16-0474
“Assessment of the Safety of Allogeneic Umbilical Cord Blood Infusions in Children With Cerebral Palsy – Full Text View.” Full Text View – ClinicalTrials.gov, https://clinicaltrials.gov/ct2/show/NCT02599207
Moise K Jr. Umbilical cord stem cells. Obstet Gynecol. 2005;106(6):1393-1407
Facebook.com/bioinformantworldwide. “When Did Banking Cord Blood Start?: Brief History.” BioInformant, 11 Oct. 2018, https://bioinformant.com/cord-blood-banking-start/
“Leadership.” Cleveland Cord Blood, https://www.clevelandcordblood.org/about/leadership/
Carpenter, Kimberly L. H., et al. “White Matter Tract Changes Associated with Clinical Improvement in an Open‐Label Trial Assessing Autologous Umbilical Cord Blood for Treatment of Young Children with Autism.” Stem Cells Journals (AlphaMed Press), John Wiley & Sons, Ltd, 8 Jan. 2019, https://stemcellsjournals.onlinelibrary.wiley.com/doi/full/10.1002/sctm.18-0251
Murias, Michael, et al. “Electrophysiological Biomarkers Predict Clinical Improvement in an Open‐Label Trial Assessing Efficacy of Autologous Umbilical Cord Blood for Treatment of Autism.” Stem Cells Journals (AlphaMed Press), John Wiley & Sons, Ltd, 1 Aug. 2018, https://stemcellsjournals.onlinelibrary.wiley.com/doi/full/10.1002/sctm.18-0090
“Stem Cell Therapy Furthers Research for Infants with Hypoplastic Left Heart Syndrome.” ScienceDaily, ScienceDaily, 23 July 2019, https://www.sciencedaily.com/releases/2019/07/190723110525.htm.
For more details and references please visit www.viacord.com/references.
Every year, employees around the globe from ViaCord and its parent company, PerkinElmer, participate in Impact Day. Impact Day focuses on local projects supporting areas of disease research, food, the environment, and newborn health.
Continuing tradition, September 12th marked PerkinElmer’s fourth annual Impact Day. 200 employees from Massachusetts alone contributed over 500 hours of volunteer time for different outreach projects benefiting a range of social causes. Projects included harvesting produce for local food pantries, lending a hand weeding and watering at farms and gardens, sorting donations for families and individuals in need, and helping prepare nutritious meals for homebound individuals and families with chronic illnesses.
“Working at PerkinElmer, throughout the year you hear about the global impact our work has on other people’s lives. But being able to have a day where you can personally give back and make a difference for those in your community is extremely rewarding.”
PerkinElmer is committed to creating better outcomes in the community by making a difference through volunteering, philanthropy and employee engagement. Employees being able to have the opportunity to participate in this companywide initiative plays an important and critical role in building a strong camaraderie between employees and in advancing the company’s mission.
At a time when researchers are just beginning to uncover the full potential of cord blood, it’s so important now more than ever to spread awareness and educate others about the amazing power these stem cells hold. Luckily, World Cord Blood Day was created to do just that! Read More
With Mother’s Day just around the corner, we thought it would be a good time to talk to one of our very own ViaCord moms – Kate Girard, RN MSN. Kate has been with ViaCord for 13 years and manages the regenerative medicine program as well as facilitates all clinical aspects of the business. Here’s the scoop on her home life, work life, and how she balances the two:
What did you do before ViaCord?
“Before ViaCord I was a travel labor and delivery nurse. The cool thing about that was I got to see how different hospitals handled their labor and delivery departments. It gave me a good perspective on multiple birthing options and settings. Each hospital had its own vibe and way of doing things. Read More
When you think about March you think of Spring, St. Patrick’s Day festivities and all of the green that comes along with it. Did you know the color green during the month of March also represents Cerebral Palsy Awareness?
Throughout the month people are encouraged to become better informed and more aware of cerebral palsy – a condition that affects approximately 1 in 323 children every year.1 Cerebral Palsy is a general term used to describe a group of disorders that can involve brain and nervous system functions, such as body movement, learning, hearing, seeing, and thinking. 2 There are several different forms of cerebral palsy and the condition is most often caused by brain injury or an abnormality in brain development. This can be a result of trauma sustained in the womb or during the early years of life.
One Little Girl’s Big Dream Makes a Big Difference during Childhood Cancer Awareness Month | ViaCord
Throughout September thousands of feet across the country have been hitting the pavement with one goal in sight – walk/run ONE MILLION MILES. Why? Because every step taken will help raise money for childhood cancer research through Alex’s Lemonade Stand Foundation’s (ALSF) ‘Million Mile Run’. With so many lives affected by this devastating disease, including some ViaCord families, we were both excited and honored to come together as Team ViaCord to contribute as many miles as possible!
Alex’s Legendary Lemonade Stand Is Born
At 4-years-old Alexandra “Alex” Scott was a girl on a mission to help find a cure for all childhood cancers. A cancer patient herself, diagnosed shortly before her first birthday with neuroblastoma, Alex told her parents she wanted to raise one million dollars for the cause. How did she plan to do this? The best way a kid knows how – with a lemonade stand in her front yard, of course! In 2004, when Alex sadly lost her battle with cancer at age 8, the foundation bearing her name
pledged to carry on her dream of finding a cure through raising funds for research. The ‘Million Mile Run’ was created specially in support of September’s Childhood Cancer Awareness Month.